Current Treatments
BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis

AVONEX® (Interferon beta-1a) is a 166 amino acid glycoprotein with a predicted molecular weight of approximately 22,500 daltons. It is produced by recombinant DNA technology using genetically engineered Chinese Hamster Ovary cells into which the human interferon beta gene has been introduced. The amino acid sequence of AVONEX® is identical to that of natural human interferon beta.

COPAXONE is the brand name for glatiramer acetate (formerly known as copolymer-1). Glatiramer acetate, the active ingredient of COPAXONE, consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. The average molecular weight of glatiramer acetate is 5,000 – 9,000 daltons. Glatiramer acetate is identified by specific antibodies.

Rebif® (interferon beta-1a) is a purified 166 amino acid glycoprotein with a molecular weight of approximately 22,500 daltons. It is produced by recombinant DNA technology using genetically engineered Chinese Hamster Ovary cells into which the human interferon beta gene has been introduced. The amino acid sequence of Rebif® is identical to that of natural fibroblast derived human interferon beta. Natural interferon beta and interferon beta-1a (Rebif®) are glycosylated with each containing a single N-linked complex carbohydrate moiety.

Tysabri is a monoclonal antibody that affects the actions of the body's immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. Tysabri is used to treat relapsing forms of multiple sclerosis. 		Gilenya™ is a new class of medication called a phingosine 1-phosphate receptormodulator, which is thought to act by retaining certain white blood cells (lympohcytes) in the lymph nodes, thereby preventing those cells from crossing the blood-brain barrier into the central nervous system (CNS). Preventing the entry of these cells into the CNS reduces inflammatory damage to nerve cells.

Early Symptoms
The most common early symptoms of MS include:
* Tingling * Numbness
* Loss of balance
* Weakness in one or more limbs
* Blurred or double vision

Less common symptoms of MS may include
* Slurred speech
* Sudden onset of paralysis
* Lack of coordination
* Cognitive difficulties
Listed above, the early symptoms. I tend to be a poster child for these. The symptoms that occur later on are too numerous just to list. There will be a link included that will get you to a site where these symptoms are listed and explained. Keep in mind that someone may have some of these or many of these, there is no way to tell.
Multiple sclerosis statistics show that approximately 250,000 to 350,000 people in the United States have been diagnosed with this disease. The life expectancy for people with multiple sclerosis is nearly the same as for those without MS. Because of this, multiple sclerosis statistics place the annual cost of MS in the United States in the billions of dollars. MS is five times more prevalent in temperate climates -- such as those found in the northern United States, Canada, and Europe -- than in tropical regions. Furthermore, the age of 15 seems to be significant in terms of risk for developing the disease. Some studies indicate that a person moving from a high-risk (temperate) to a low-risk (tropical) area before the age of 15 tends to adopt the risk (in this case, low) of the new area and vice versa. Other studies suggest that people moving after age 15 maintain the risk of the area where they grew up.

Tuesday, May 3, 2011

Conventional medicine finally admits MS caused by vitamin D deficiency Learn more: http://www.naturalnews.com/032244_multiple_sclerosis_vitamin_D_deficiency.

Friday, April 29, 2011 by: M.K. Tyler




3035Share
Share/Save/Bookmark
Get daily news updates from the Health Ranger

Your email privacy is 100% protected.
(NaturalNews) Is it true that those who suffer from Multiple sclerosis (MS) just need a little sun? Researchers at the University of Oxford seem to think so. In 2006, a study by the Journal of the American Medical Association suggested higher levels of vitamin D might decrease overall risk of developing MS. Now researchers at the University of Oxford are backing that study with further evidence while also suggesting a link between lack of sunlight and how the body responds when faced with an infection. The research concludes that MS is caused by several factors working in combination but clearly correlates to a lack of vitamin D.

Is it really as simple as soaking up some rays?

While the phenomenon of vitamin D deficiency is seen all over the world, countries in the northern hemisphere have been linked to significantly higher rates of MS. Scotland, for example, has one of the largest populations of MS sufferers, while the disease is "virtually unknown" in Africa. Even in sunny areas of the globe, it's not uncommon for people to become vitamin D deficient during the winter, as the sun's rays aren't often high enough to penetrate atmospheric layers.

The research put forth by the University of Oxford suggests that, while those who already have MS may not benefit exponentially simply by increasing levels of vitamin D, getting more sun could be an effective preventative measure against developing the disease and managing symptoms.

More importantly, MS sufferers may be able to boost immunity to other conditions with an increase in vitamin D. A recent study by Anticancer Research affirms that typical adults need much more than the daily dosage recommended by the U.S. Government. According to that research, 4,000-8,000 IUs of vitamin D every day could not only help prevent MS but also several types of cancer and Type 1 diabetes.

The health care industry, of course, won't promote a natural and safe preventative measure for degenerative diseases. Instead, people are warned about the dangers of UV exposure and the risks of vitamin toxicity. With vitamin D deficiency afflicting 90% of the U.S. population, however, it may be time to get a tan. Here are some interesting facts about the relationship between vitamin D and health:

1. It's free. Five to thirty minutes of sunlight a couple of times a week is usually sufficient for helping the body create enough vitamin D
2. Getting enough vitamin D from food is virtually impossible
3. Sunscreens may block the body's ability to generate vitamin D
4. Vitamin D is essential for the absorption of calcium in the body
5. Those who live further from the equator generally require longer periods of sun exposure to generate enough vitamin D
6. A lack of vitamin D can affect bone strength. One theory suggests that women who are deficient in vitamin D can suffer from contracting pelvises, which can result in the death of babies during labor
7. Vitamin D deficiency cannot be reversed quickly. It takes months for the body to increase and regulate vitamin D levels. This is why short periods of sun exposure are not only safe but also necessary for the synthesis of this important substance

For those with MS, increased sun exposure may be an easy and safe preventative measure against further cognitive and physical degeneration. As a direct threat to the medical establishment, however, it remains to be seen whether further government warnings and regulations about vitamin D will eventually ban people from sun bathing.

Sources for this article include

http://www.bbc.co.uk/news/health-13...
http://health.usnews.com/usnews/hea...
http://www.guardian.co.uk/science/2...

Articles Related to This Article:

Learn more: http://www.naturalnews.com/032244_multiple_sclerosis_vitamin_D_deficiency.html#ixzz1LJhaXLsp
Posted by Steve at Tuesday, May 03, 2011

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

About Me

My photo
North Grafton, Massachusetts, United States
Well-educated, disabled at this point with Multiple Sclerosis. I am very glad that I was able to do the things that I have been able to do over the years. had to change the picture, this one's more realistic.